WebDisclosure WebDisclosure
Basculer en Français
9551 Companies
188477 Keywords
120311 Articles
100641 Press releases
Headlines Articles Press releases United Health Products, Inc. Remove
  1. Home
  2. Companies
  3. United Health Products, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/19/2024 at 14:40, 1 year 10 months ago

    United Health Products Reports on FDA Application Status

    United Health Products (UEEC) reports on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze as part of its FDA application process. The reported data on the efficacy of the proposed radiation sterilization protocol were well within acceptable bioburden levels for Class III products, and the company will proceed with final drafting of the PMA documentation for submission. The press release raises awareness about the company's ongoing FDA application status and its pursuit of approval for its hemostatic products.
    United Health Products UEEC FDA Application Status Hemostatic Gauze Premarket Approval Application
    Logo of United Health Products, Inc.
Accesswire
  • Published on 12/18/2025 at 18:00, 2 hours 25 minutes ago

    PPX Mining Announces 2025 AGM Results

  • Published on 12/18/2025 at 15:00, 5 hours 25 minutes ago

    Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia

  • Published on 12/18/2025 at 14:31, 5 hours 54 minutes ago

    Worksport Reports Highest Monthly Revenue in Company History

  • Published on 12/18/2025 at 14:00, 6 hours 25 minutes ago

    Route1 Announces Provisional Patent Application

  • Published on 12/18/2025 at 14:00, 6 hours 25 minutes ago

    LQR House Announces $6.52 Million Registered Direct Offering

View all ACCESSWIRE
EQS Group
  • Published on 12/18/2025 at 20:09, 16 minutes ago

    EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond

  • Published on 12/18/2025 at 19:30, 55 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT

  • Published on 12/18/2025 at 19:30, 55 minutes ago

    Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST

  • Published on 12/18/2025 at 18:48, 1 hour 37 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 12/18/2025 at 18:45, 1 hour 40 minutes ago

    PATRIMOINE ET COMMERCE: PROJET D’AUGMENTATIONS DE CAPITAL DE PATRIMOINE & COMMERCE D’UN MONTANT DE 30 MILLIONS D’EUROS

View all EQS
Les Echos
  • Published on 12/18/2025 at 18:30, 1 hour 55 minutes ago

    Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

  • Published on 12/18/2025 at 18:30, 1 hour 55 minutes ago

    Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde

  • Published on 12/18/2025 at 17:45, 2 hours 40 minutes ago

    Cie du Bois Sauvage: Vernietiging eigen aandelen

  • Published on 12/18/2025 at 17:45, 2 hours 40 minutes ago

    Damartex réaffirme son éligibilité au PEA-PME

  • Published on 12/18/2025 at 17:45, 2 hours 40 minutes ago

    Cie du Bois Sauvage : Cancellation of own shares

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy